Corporate ActionJun 3, 2026, 04:22 PM
Cue Biopharma Stockholders Approve 2026 Stock Plan & Share Issuance
AI Summary
Cue Biopharma's stockholders approved the 2026 Stock Incentive Plan at a Special Meeting held on June 1, 2026. Additionally, stockholders approved the issuance of common stock upon the exercise of warrants issued in May 2026, which were connected to a licensing transaction and related private placement. Both key proposals received sufficient votes for approval.
Key Highlights
- Stockholders approved the 2026 Stock Incentive Plan.
- Stockholders approved the issuance of common stock for warrants from a May 2026 licensing transaction and private placement.
- Proposal 1 (share issuance) received 1,782,133 'For' votes.
- Proposal 2 (2026 Plan) received 1,261,296 'For' votes.
- Proposal 3 (adjournment) was approved but not necessary as other proposals passed.
Price Impact
More from CUE